DOCUMENTS

papers

Medication oversupply in patients with diabetes

Published: September 11, 2014
Category: Papers
Authors: Chewning B, Dopp AL, Everett CM, Johnson H, Mott DA, Palta M, Ronk K, Schleiden L, Smith MA, Thorpe CT, Thorpe JM
Country: United States
Language: null
Type: Population Health
Settings: Health Plan, PCP

Res Social Adm Pharm 11:382-400.

Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA, USA; University of Pittsburgh, PA, USA; University of Wisconsin, Madison, WI, USA; Pharmacy Society of Wisconsin, Madison, WI, USA; Duke University Medical Center, Durham, NC, USA

BACKGROUND: Studies in integrated health systems suggest that patients often accumulate oversupplies of prescribed medications, which is associated with higher costs and hospitalization risk. However, predictors of oversupply are poorly understood, with no studies in Medicare Part D.

OBJECTIVE: The aim of this study was to describe prevalence and predictors of oversupply of antidiabetic, antihypertensive, and antihyperlipidemic medications in adults with diabetes managed by a large, multidisciplinary, academic physician group and enrolled in Medicare Part D or a local private health plan.

METHODS: This was a retrospective cohort study. Electronic health record data were linked to medical and pharmacy claims and enrollment data from Medicare and a local private payer for 2006-2008 to construct a patient-quarter dataset for patients managed by the physician group. Patients’ quarterly refill adherence was calculated using ReComp, a continuous, multiple-interval measure of medication acquisition (CMA), and categorized as 1.20 = Oversupply. We examined associations of baseline and time-varying predisposing, enabling, and medical need factors to quarterly supply using multinomial logistic regression.

RESULTS: The sample included 2519 adults with diabetes. Relative to patients with private insurance, higher odds of oversupply were observed in patients aged 65 in Medicare (OR = 3.36, 95% CI = 1.61-6.99), patients 65+ in Medicare (OR = 2.51, 95% CI = 1.37-4.60), patients 65 in Medicare/Medicaid (OR = 4.55, 95% C = 2.33-8.92), and patients 65+ in Medicare/Medicaid (OR = 5.73, 95% CI =2.89-11.33). Other factors associated with higher odds of oversupply included any 90-day refills during the quarter, psychotic disorder diagnosis, and moderate versus tight glycemic control.

CONCLUSIONS: Oversupply was less prevalent than in previous studies of integrated systems, but Medicare Part D enrollees had greater odds of oversupply than privately insured individuals. Future research should examine utilization management practices of Part D versus private health plans that may affect oversupply.

PMID: 25288448
PMCID: PMC4362914

United States,Prescription Drug Use and Expenditures,Medications,Resource Use,Age Factors,Aged,Antihypertensive Agents/supply & distribution,Cohort Studies,Drug Prescription/statistics & numerical data,Drug Utilization/statistics & numerical data,Electronic Health Records,Gender,Hypoglycemic Agents/supply & distribution,Hypolipidemic Agents/supply & distribution,International Classification of Diseases,Medicare Part D,Medication Adherence,Middle Aged,Retrospective Studies,Sex Factors,Wisconsin

Please log in/register to access.

Log in/Register

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System.
All rights reserved. Terms of Use Privacy Statement

Back to top